Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With Osteoporosis
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine how teriparatide or denosumab affects the bone of
postmenopausal women with osteoporosis after 3 months of treatment, as determined by a bone
biopsy sample taken from the iliac crest (upper part of the pelvis).